Detection of serum mitochondria aspartate aminotransferase by immunosuppression method and the relationship between the enzyme activity and liver injury
Shao Zhexi
Abstract
Shao Zhexi
Abstract
Objective To establish a immunosuppression assay for detecting serum mitochondria aspartate aminotransferase (m-AST) isoenzyme and to understand the relationship among the m-AST activities and the severity of liver injury. Methods Activities finelinearity of m-AST and total AST in sera from 82 healthy individuals, 33 chronic hepatitis (CH) and 19 fulminant hepatitis (FH) patients, and then the m-AST/AST ratios was calculated. Results A fine linearity of m-AST activity by this assay was found in range of 200U/L. Coefficient of variations within-run and between-run were less than 3.71% and 3.91% respectively. The recovery rates were from 96.3% to 104.6% and mean of the rates was 100.5%. In serum samples from the healthy individuals, m-AST activity values were 1.1±0.4U/L and m-AST/AST ratios were and 5.7±1.8%. m-AST activity values and m-AST/AST ratios were 82.6±30.9U/L and 26.1±22.5% for 33 CH patients and 152.9±29.5 U/L and 30.5±25.2% for FH patients, respectively. A high statistically significances could be found in the comparison of the m-AST activity values and m-AST/AST ratios beween the patients and normal controls (P0.01). The serum m-AST activity values and m-AST/AST ratios between CH and FH patients were also significantly different (P0.01). Conclusions The immunosuppression assay used in this study is a simple, rapid and well-repeated method for detecting serum m-AST activity. m-AST activities in sera is able to reflect severity of liver injury.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To establish a immunosuppression assay for detecting serum mitochondria aspartate aminotransferase (m-AST) isoenzyme and to understand the relationship among the m-AST activities and the severity of liver injury. Methods Activities finelinearity of m-AST and total AST in sera from 82 healthy individuals, 33 chronic hepatitis (CH) and 19 fulminant hepatitis (FH) patients, and then the m-AST/AST ratios was calculated. Results A fine linearity of m-AST activity by this assay was found in range of 200U/L. Coefficient of variations within-run and between-run were less than 3.71% and 3.91% respectively. The recovery rates were from 96.3% to 104.6% and mean of the rates was 100.5%. In serum samples from the healthy individuals, m-AST activity values were 1.1±0.4U/L and m-AST/AST ratios were and 5.7±1.8%. m-AST activity values and m-AST/AST ratios were 82.6±30.9U/L and 26.1±22.5% for 33 CH patients and 152.9±29.5 U/L and 30.5±25.2% for FH patients, respectively. A high statistically significances could be found in the comparison of the m-AST activity values and m-AST/AST ratios beween the patients and normal controls (P0.01). The serum m-AST activity values and m-AST/AST ratios between CH and FH patients were also significantly different (P0.01). Conclusions The immunosuppression assay used in this study is a simple, rapid and well-repeated method for detecting serum m-AST activity. m-AST activities in sera is able to reflect severity of liver injury.
Key concepts: Immunosuppression, Internal medicine, Medicine, Gastroenterology, Hepatitis